Cryo-Cell International Inc (CCEL) is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of significant positive catalysts, weak technical indicators, and declining financial performance suggest that holding off on investment is prudent. There are no clear signs of upward momentum or strong growth prospects.
The technical indicators for CCEL are bearish. The MACD histogram is below 0 and negatively contracting, indicating weak momentum. The RSI is neutral at 60.396, providing no clear signal. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading near its pivot level of 3.067, with resistance at 3.208 and support at 2.925.
NULL identified. There is no recent news, no significant insider or hedge fund activity, and no recent congress trading data.
Financial performance shows a YoY revenue decline of -2.26%, and gross margin has dropped by -2.09%. Additionally, the stock has bearish technical indicators and lacks upward momentum.
In Q4 2025, revenue dropped by -2.26% YoY to $7,843,166. Net income improved by 105.06% YoY but remains negative at -$3,817,433. EPS increased by 104.35% YoY to -0.47, but it is still negative. Gross margin decreased by -2.09% YoY to 75.55%. Overall, the financials show mixed signals with no strong growth trends.
No analyst rating or price target data available.